AI assistant
BioAtla, Inc. — Director's Dealing 2022
Jun 9, 2022
34681_dirs_2022-06-09_f67c09bb-30d6-4c18-9d64-5460248e35df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2022-06-07
Reporting Person: Vasquez Christian (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-06-07 | Common Stock | P | 14152 | $3.0389 | Acquired | 38677 | Direct |
| 2022-06-08 | Common Stock | P | 25848 | $3.0249 | Acquired | 64525 | Direct |
| 2022-06-09 | Common Stock | P | 10000 | $2.972 | Acquired | 74525 | Direct |
Footnotes
F1: The range of prices for the shares of Common Stock is from $2.66 to $3.10. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
F2: The range of prices for the shares of Common Stock is from $2.98 to $3.05. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.
F3: The range of prices for the shares of Common Stock is from $2.93 to $3.00. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.